{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:42:51Z","timestamp":1793716971785,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.forsciint.2005.06.007","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T21:24:29Z","timestamp":1122585869000},"page":"229-236","source":"Crossref","is-referenced-by-count":23,"title":["Tissue distribution of mirtazapine and desmethylmirtazapine in a case of mirtazapine poisoning"],"prefix":"10.1016","volume":"156","author":[{"given":"Stephanie","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Aderjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Pedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Skopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2005.06.007_bib1","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(94)90778-1","article-title":"The \u03b12-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo","volume":"253","author":"de Boer","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0028-3908(88)90149-9","article-title":"Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers","volume":"27","author":"de Boer","year":"1988","journal-title":"Neuropharmacology"},{"issue":"Suppl. 4","key":"10.1016\/j.forsciint.2005.06.007_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-199512004-00006","article-title":"Safety of mirtazapine: a review","volume":"10","author":"Montgomery","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2005.06.007_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200038060-00001","article-title":"Clinical pharmacokinetics of mirtazapine","volume":"38","author":"Timmer","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2005.06.007_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/(SICI)1099-1077(199611)11:6<497::AID-HUP820>3.0.CO;2-J","article-title":"Pharmacokinetics of mirtazapine from orally administered tablets: influence of gender, age and treatment regimen","volume":"11","author":"Timmer","year":"1996","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hup.470100803","article-title":"Bioavailability of mirtazapine after single and multiple oral dosing","volume":"10","author":"Voortman","year":"1995","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00044011-199713010-00005","article-title":"In vitro and in vivo studies on the disposition of mirtazapine in humans","volume":"13","author":"Dahl","year":"1997","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.forsciint.2005.06.007_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00044011-199815010-00006","article-title":"Pharmacokinetics and biotransformation of mirtazapine in human volunteers","volume":"15","author":"Delbressine","year":"1998","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.forsciint.2005.06.007_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0014-2999(90)93499-G","article-title":"Contribution of the enantiomers of mirtazapine (Org 3770) and its demethyl metabolite to its neuropharmacological profile in rats","volume":"183","author":"De Graaf","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(98)00460-5","article-title":"High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and 1st demethyl metabolite in human plasma","volume":"721","author":"Maris","year":"1999","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.forsciint.2005.06.007_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007691-200406000-00010","article-title":"Therapeutic drug monitoring of mirtazapine and its metabolite desmethylmirtazapine by HPLC with fluorescence detection","volume":"26","author":"Meinecke","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.forsciint.2005.06.007_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00007691-200408000-00005","article-title":"Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomeres of mirtazapine, N-demethylmirtazapine and 8-hydroxymirtazapine by LC\u2013MS","volume":"26","author":"Paus","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2005.06.007_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jat\/23.6.544","article-title":"Distribution of mirtazapine (Remeron\u00ae) in thirteen postmortem cases","volume":"23","author":"Anderson","year":"1999","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jat\/23.6.541","article-title":"Tissue distribution of mirtazapine (Remeron\u00ae) in postmortem cases","volume":"23","author":"Moore","year":"1999","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.forsciint.2005.06.007_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0378-4347(87)80109-3","article-title":"Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasma","volume":"417","author":"Paanakker","year":"1987","journal-title":"J. Chromatogr."},{"issue":"5","key":"10.1016\/j.forsciint.2005.06.007_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4088\/JCP.v59n0505","article-title":"Safety of mirtazapine in overdose","volume":"59","author":"Bremner","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"9","key":"10.1016\/j.forsciint.2005.06.007_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0006-3223(98)00081-X","article-title":"Suicide attempts with mirtazapine overdose without complications","volume":"44","author":"Holzbach","year":"1998","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.forsciint.2005.06.007_bib18","first-page":"342","article-title":"Relative safety of mirtazapine in overdose","volume":"43","author":"Valezquez","year":"2001","journal-title":"Vet. Hum. Toxicol."},{"issue":"2","key":"10.1016\/j.forsciint.2005.06.007_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1440-1614.2003.t01-7-01138.x","article-title":"A non-fatal mirtazapine overdose in a suicide attempt","volume":"37","author":"Garlipp","year":"2003","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.forsciint.2005.06.007_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4088\/JCP.v58n0607a","article-title":"Safety in overdose of mirtazapine: a case report","volume":"58","author":"Gerritsen","year":"1997","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.forsciint.2005.06.007_bib21","first-page":"67","article-title":"Comparative toxicity of citalopram and the newer antidepressants after overdose","volume":"42","author":"Kelly","year":"2004","journal-title":"J. Toxicol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib22","unstructured":"M.D. Robertson, P.S. Ng, S.B. Gore, Death due to mirtazapine (Remeron) toxicity, Annual meeting of the Society of Forensic Toxicologists, Puerto Rico, 1999 (Abstract)."},{"key":"10.1016\/j.forsciint.2005.06.007_bib23","unstructured":"Organon, Mirtazapine Product Information, 2000."},{"key":"10.1016\/j.forsciint.2005.06.007_bib24","unstructured":"Deutsches Institut f\u00fcr Normung, DIN 32645 Chemische Analytik: Nachweis-, Erfassungs-und Bestimmungsgrenze, Beuth, Berlin, 1994, pp. 3\u201310."},{"key":"10.1016\/j.forsciint.2005.06.007_bib25","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2002"},{"key":"10.1016\/j.forsciint.2005.06.007_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.forsciint.2004.02.012","article-title":"Preanalytical aspects in postmortem toxicology","volume":"142","author":"Skopp","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2005.06.007_bib27","first-page":"2189","article-title":"Vasopressin analogue injection as ultimate measure for counteracting severe catecholamine-refractory poisoning by several vasodilators taken with suicidal intent","volume":"128","author":"Weisberger","year":"2003","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"2","key":"10.1016\/j.forsciint.2005.06.007_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hup.441","article-title":"Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects","volume":"18","author":"Sennef","year":"2003","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2005.06.007_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004714-199704000-00007","article-title":"CYP 2D6 inhibition in patients treated with sertraline","volume":"17","author":"Sproule","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2005.06.007_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1345\/aph.1D344","article-title":"Serotonine syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine","volume":"38","author":"Houlihan","year":"2004","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.forsciint.2005.06.007_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2007-979550","article-title":"Mirtazapine as treatment for serotonine syndrome","volume":"29","author":"Hoes","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"10.1016\/j.forsciint.2005.06.007_bib32","first-page":"453","article-title":"Mirtazapine-induced hyponatraemia","volume":"179","author":"Roxanas","year":"2003","journal-title":"M.J.A."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073805003907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073805003907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:58:57Z","timestamp":1548313137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073805003907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":32,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0379073805003907"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2005.06.007","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}